hexobarbital has been researched along with rilmenidine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
de Jonge, A; Jonkman, FA; Thoolen, MJ; Timmermans, PB; van Zwieten, PA; Wilffert, B | 1 |
Van Zwieten, PA | 1 |
3 other study(ies) available for hexobarbital and rilmenidine
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Central and peripheral effects of S 3341 [(N-dicyclopropylmethyl)-amino-2-oxazoline] in animal models.
Topics: Adrenergic alpha-Agonists; Animals; Binding, Competitive; Blood Pressure; Brain; Cats; Clonidine; Decerebrate State; Female; Heart Rate; Hexobarbital; In Vitro Techniques; Male; Mice; Oxazoles; Prazosin; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Rilmenidine; Sleep; Time Factors | 1986 |
Pharmacology of the alpha 2-adrenoceptor agonist rilmenidine.
Topics: Adrenergic alpha-Agonists; Animals; Blood Pressure; Central Nervous System; Chemical Phenomena; Chemistry; Clonidine; Dose-Response Relationship, Drug; Hexobarbital; Humans; Hypnotics and Sedatives; Mice; Oxazoles; Rats; Rilmenidine; Sleep | 1988 |